farglitazar has been researched along with ici 118551 in 1 studies
| Studies (farglitazar) | Trials (farglitazar) | Recent Studies (post-2010) (farglitazar) | Studies (ici 118551) | Trials (ici 118551) | Recent Studies (post-2010) (ici 118551) |
|---|---|---|---|---|---|
| 35 | 3 | 5 | 836 | 31 | 106 |
| Protein | Taxonomy | farglitazar (IC50) | ici 118551 (IC50) |
|---|---|---|---|
| Beta-2 adrenergic receptor | Homo sapiens (human) | 0.0007 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baer, PG; Bennett, T; Brown, KK; Gardiner, SM; Nunez, DJ | 1 |
1 other study(ies) available for farglitazar and ici 118551
| Article | Year |
|---|---|
Regional hemodynamic effects of the N-(2-benzoylphenyl)-L-tyrosine peroxisome proliferator-activated receptor-gamma ligand, GI 262570 [(S)-2-(2-benzoylphenylamino)-3-[4-[2-(5-methyl-2-phenyl-2-oxazol-4-yl)ethoxy]phenyl]propionic acid], in conscious rats.
Topics: Acetylcholine; Animals; Hemodynamics; Indans; Male; Methoxamine; Naphthyridines; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxazoles; Phentolamine; Propanolamines; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Transcription Factors; Tyrosine | 2004 |